GI
VRDN icon

GAMMA Investing’s Viridian Therapeutics VRDN Stock Holding History

GAMMA Investing’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.5K Buy
800
+338
+73% +$7.21K ﹤0.01% 3060
2026
Q2 		$8.49K Buy
462
+4
+0.9% +$64 ﹤0.01% 3286
2026
Q1 		$8.96K Sell
458
-19
-4% -$564 ﹤0.01% 3120
2025
Q4 		$14.8K Buy
477
+165
+53% +$4.53K ﹤0.01% 2780
2025
Q3 		$6.73K Sell
312
-9
-3% -$162 ﹤0.01% 3058
2025
Q2 		$4.49K Sell
321
-304
-49% -$4.13K ﹤0.01% 3167
2025
Q1 		$8.43K Buy
625
+414
+196% +$7.05K ﹤0.01% 2833
2024
Q4 		$4.04K Buy
211
+24
+13% +$522 ﹤0.01% 2999
2024
Q3 		$4.25K Buy
187
+176
+1,600% +$2.88K ﹤0.01% 2811
2024
Q2 		$143 Sell
11
-95
-90% -$1.31K ﹤0.01% 3389
2024
Q1 		$1.86K Buy
106
+73
+221% +$1.42K ﹤0.01% 2767
2023
Q4 		$635 Buy
+33
New +$521 ﹤0.01% 2909

Other funds holding VRDN

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing's VRDN Position: Q3 2026 in Review

GAMMA Investing increased its Viridian Therapeutics (VRDN) stake by 73% in Q3 2026, buying an estimated $7.21K and bringing the position to 800 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3060.

GAMMA Investing first reported a position in VRDN in Q4 2023 and has held it in 12 quarters since. 3 funds tracked by Wall St. Rank hold VRDN as of Q3 2026.

  • GAMMA Investing held 800 shares of Viridian Therapeutics worth $16.5K as of Q3 2026.
  • GAMMA Investing bought 338 Viridian Therapeutics shares in Q3 2026, an estimated $7.21K.
  • Viridian Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3060 holding.
  • GAMMA Investing first reported a position in Viridian Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • 3 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.